Prognosis after TIPSS using MELD Score
Model for End-Stage Liver Disease (MELD) is a numerical score based on a patient’s risk of dying while waiting for a liver transplant; mortality at 90 days for alcoholic hepatitis can also be used to guide in treatment decisions in patients with alcoholic hepatitis, especially if complicated by ascites and/or encephalopathy. The maximum serum creatinine considered within the MELD score is 350 µmol/L; if a patient has had dialysis more than twice in the past week or has a Cr > 350 µmol/L, then the maximum value will be entered.
A MELD score of >18 is considered high risk. Patients with a MELD score of >14 had a median survival of <90 days with insertion of TIPSS.
- [1]Angermayr B et al.: Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.Gut 2003, 52 (6): 879-85
- [2]Schepke M et al.: Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.American Journal of Gastroenterology 2003, 98 (5): 1167-74
Results
Real-time automated computation
Model for End-Stage Liver Disease (MELD) is a numerical score based on a patient’s risk of dying while waiting for a liver transplant; mortality at 90 days for alcoholic hepatitis can also be used to guide in treatment decisions in patients with alcoholic hepatitis, especially if complicated by ascites and/or encephalopathy. The maximum serum creatinine considered within the MELD score is 350 µmol/L; if a patient has had dialysis more than twice in the past week or has a Cr > 350 µmol/L, then the maximum value will be entered.
A MELD score of >18 is considered high risk. Patients with a MELD score of >14 had a median survival of <90 days with insertion of TIPSS.
- [1]Angermayr B et al.: Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.Gut 2003, 52 (6): 879-85
- [2]Schepke M et al.: Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.American Journal of Gastroenterology 2003, 98 (5): 1167-74